Product Code: ETC044949 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Philippines chemotherapy market is expected to grow at a compound annual growth rate (CAGR) of 4.2% during the forecast period 2020-2026. The rising prevalence of cancer, increasing geriatric population and improved healthcare infrastructure are some major factors driving the growth of the chemotherapy market in the Philippines. Furthermore, increasing R&D activities by leading players present in this region coupled with growing government initiatives to provide easy access to treatments for cancer patients will further fuel the growth opportunities for chemotherapy drugs during the forecast period 2020-2026
However, inappropriate doses and wrong medications may limit patient outcomes and increase treatment costs that can restrain market growth over the forecast period 2020-2026. Additionally, stringent regulatory policies imposed by government agencies such as FDA due to safety concerns have also hindered product approvals which could lead to delayed launch or withdrawal from certain markets ultimately hampering business margins of industry participants operating across these regions
Moreover, Covid 19 pandemic has disrupted supply chain operations as well as halted clinical trials & research studies affecting drug development process significantly impacting entire pharmaceutical industry including chemotherapy drugs manufacturers negatively due to reduced demand & production capacity forcing them into uncertain conditions resulting into increased financial burden on them thus restraining market???s expansion further over near future
Some of key players operating in Philippines Chemotherapy Market include Pfizer Inc., Bristol Myers Squibb Co., Novartis AG, Sanofi SA , Merck KGaA among others
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Chemotherapy Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Chemotherapy Market Revenues & Volume, 2020 & 2030F |
3.3 Philippines Chemotherapy Market - Industry Life Cycle |
3.4 Philippines Chemotherapy Market - Porter's Five Forces |
3.5 Philippines Chemotherapy Market Revenues & Volume Share, By Drug Class, 2020 & 2030F |
3.6 Philippines Chemotherapy Market Revenues & Volume Share, By Indication, 2020 & 2030F |
3.7 Philippines Chemotherapy Market Revenues & Volume Share, By Route of Drug Administration, 2020 & 2030F |
3.8 Philippines Chemotherapy Market Revenues & Volume Share, By End-Users, 2020 & 2030F |
4 Philippines Chemotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Chemotherapy Market Trends |
6 Philippines Chemotherapy Market, By Types |
6.1 Philippines Chemotherapy Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Philippines Chemotherapy Market Revenues & Volume, By Drug Class, 2020-2030F |
6.1.3 Philippines Chemotherapy Market Revenues & Volume, By Alkylating Agents, 2020-2030F |
6.1.4 Philippines Chemotherapy Market Revenues & Volume, By Mitotic Inhibitors, 2020-2030F |
6.1.5 Philippines Chemotherapy Market Revenues & Volume, By Antimetabolites, 2020-2030F |
6.1.6 Philippines Chemotherapy Market Revenues & Volume, By Topoisomerase Inhibitors, 2020-2030F |
6.1.7 Philippines Chemotherapy Market Revenues & Volume, By Antitumor Antibiotic, 2020-2030F |
6.2 Philippines Chemotherapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Philippines Chemotherapy Market Revenues & Volume, By Lung Cancer, 2020-2030F |
6.2.3 Philippines Chemotherapy Market Revenues & Volume, By Breast Cancer, 2020-2030F |
6.2.4 Philippines Chemotherapy Market Revenues & Volume, By Colorectal Cancer, 2020-2030F |
6.2.5 Philippines Chemotherapy Market Revenues & Volume, By Prostate Cancer, 2020-2030F |
6.2.6 Philippines Chemotherapy Market Revenues & Volume, By Stomach Cancer, 2020-2030F |
6.2.7 Philippines Chemotherapy Market Revenues & Volume, By Lymphoma, 2020-2030F |
6.2.8 Philippines Chemotherapy Market Revenues & Volume, By Ovarian Cancer, 2020-2030F |
6.2.9 Philippines Chemotherapy Market Revenues & Volume, By Ovarian Cancer, 2020-2030F |
6.3 Philippines Chemotherapy Market, By Route of Drug Administration |
6.3.1 Overview and Analysis |
6.3.2 Philippines Chemotherapy Market Revenues & Volume, By Intravenous, 2020-2030F |
6.3.3 Philippines Chemotherapy Market Revenues & Volume, By Oral, 2020-2030F |
6.3.4 Philippines Chemotherapy Market Revenues & Volume, By Subcutaneous, 2020-2030F |
6.3.5 Philippines Chemotherapy Market Revenues & Volume, By Intra-Muscular, 2020-2030F |
6.3.6 Philippines Chemotherapy Market Revenues & Volume, By Intravesicular, 2020-2030F |
6.3.7 Philippines Chemotherapy Market Revenues & Volume, By Topical, 2020-2030F |
6.3.8 Philippines Chemotherapy Market Revenues & Volume, By Intraventricular/Intrathecal, 2020-2030F |
6.3.9 Philippines Chemotherapy Market Revenues & Volume, By Intraventricular/Intrathecal, 2020-2030F |
6.4 Philippines Chemotherapy Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Philippines Chemotherapy Market Revenues & Volume, By Specialty Centers, 2020-2030F |
6.4.3 Philippines Chemotherapy Market Revenues & Volume, By Hospitals & Clinics, 2020-2030F |
7 Philippines Chemotherapy Market Import-Export Trade Statistics |
7.1 Philippines Chemotherapy Market Export to Major Countries |
7.2 Philippines Chemotherapy Market Imports from Major Countries |
8 Philippines Chemotherapy Market Key Performance Indicators |
9 Philippines Chemotherapy Market - Opportunity Assessment |
9.1 Philippines Chemotherapy Market Opportunity Assessment, By Drug Class, 2020 & 2030F |
9.2 Philippines Chemotherapy Market Opportunity Assessment, By Indication, 2020 & 2030F |
9.3 Philippines Chemotherapy Market Opportunity Assessment, By Route of Drug Administration, 2020 & 2030F |
9.4 Philippines Chemotherapy Market Opportunity Assessment, By End-Users, 2020 & 2030F |
10 Philippines Chemotherapy Market - Competitive Landscape |
10.1 Philippines Chemotherapy Market Revenue Share, By Companies, 2023 |
10.2 Philippines Chemotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |